Respiratory tract

Respiratory Multi-Detection Kit (for SARS-CoV-2/Influenza A virus/Influenza B virus/Respiratory Syncytial Virus/Adenovirus+ Mycoplasma pneumoniae antigen)

The COVID-19/RSV/ADV/FLU/MP Antigen Rapid Test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative  detection and differentiation of nucleocapsid antigen from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Influenza type A  virus, Influenza type B virus, Respiratory Syncytial Virus (RSV), Adenovirus (ADV) and Mycoplasma pneumoniae (M. pneumoniae) directly  from anterior nasal swab specimens obtained from individuals, who are suspected of respiratory viral infection consistent with COVID-19 by  their healthcare providers, within the first seven days of symptoms onset.